J. Ian Mason
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
J. Ian Mason has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Georgia Papacleovoulou
Centre for Reproductive Biology, Reproductive and Developmental Sciences, The Queen's Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK
3 shared publicationsHilary O.D. Critchley
Univ Edinburgh, Queens Med Res Inst, Ctr Reprod Biol Reprod & Dev Sci, Edinburgh EH16 4TJ, Midlothian, Scotland
2 shared publicationsStephen G. Hillier
Univ Edinburgh, Queens Med Res Inst, Ctr Reprod Biol Reprod & Dev Sci, Edinburgh EH16 4TJ, Midlothian, Scotland
2 shared publications- Alexander F. Howie
Department of Veterinary Clinical Studies, Royal (Dick) School of Veterinary Studies, The University of Edinburgh, Edinburgh, EH25 9RG, UK
1 shared publication Andrew Advani
Keenan Research Centre of the Li Ka Shing Knowledge Institute, St Michael’s Hospital and University of Toronto, Toronto, Ontario, Canada
1 shared publication- Catriona Clarke
Clinical Biochemistry, Western General Hospital, Edinburgh, UK
1 shared publication
Latest Publications
- 1 July 2015
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 151, 1-2
Steroid promiscuity: Diversity of enzyme action
- 1 July 2015
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 151, 1-2
Steroid promiscuity: Diversity of enzyme action
- 1 March 2014
- Published by Bioscientifica in Endocrine Abstracts
Targeting of lysyl oxidase by steroids to reduce peritoneal fibrosis and scarring
Abdominal surgery and diseases such as endometriosis cause persistent abdominal adhesions leading to pelvic pain, infertility and in severe cases, bowel obstruction. Current treatments are ineffective and the aetiology is unclear, although excessive collagen deposition is a consistent feature. Lysyl oxidase (LOX) is a key enzyme required for crosslinking and deposition of insoluble collagen. 10–12 weeks old female C57Bl/6 mice (3–10 mice per group) were treated with 25 ng multiwalled carbon nanotubes (NT) as an i.p. insult to induce fibrosis, together with chemical (β-aminoproprionitrile – BAPN) or miRNA LOX inhibitors, progesterone (Prog) or dexamethasone (Dex) for up to 7 days. Fibrotic lesion area and Picrosirius red staining of the diaphragm, and mRNA expression of fibrosis-related genes in abdominal wall peritoneal mesothelial cells (PMC) were measured. Effects of BAPN and DEX on collagen fibre alignment were observed by transmission electron microscopy (TEM). Isolated PMC were cultured with and without interleukin 1α (IL1α) and Prog to determine effects on lox mRNA in vitro. NT induced extensive fibrosis and collagen deposition on the diaphragm, that was significantly ameliorated by BAPN, LOX miRNA, Prog or Dex. BAPN and Dex disrupted ordered collagen fibre bundles induced by NT as observed by TEM. Expression of lox, col1a1, col3a1 and bmp1 mRNA in abdominal wall PMC were all significantly increased by NT, but this effect was inhibited by treatment for up to 7 days with Prog or Dex. Physiological levels of Prog significantly inhibited IL1α induced lox expression by PMC in vitro. Our results suggest targeting of LOX in the peritoneum may ameliorate fibrosis and the development of adhesions, and point to simple, naturally occurring or widely used steroids as potential agents to prevent adhesion formation following abdominal surgery.
- 1 March 2014
- Published by Bioscientifica in Endocrine Abstracts
Targeting of lysyl oxidase by steroids to reduce peritoneal fibrosis and scarring
Abdominal surgery and diseases such as endometriosis cause persistent abdominal adhesions leading to pelvic pain, infertility and in severe cases, bowel obstruction. Current treatments are ineffective and the aetiology is unclear, although excessive collagen deposition is a consistent feature. Lysyl oxidase (LOX) is a key enzyme required for crosslinking and deposition of insoluble collagen. 10–12 weeks old female C57Bl/6 mice (3–10 mice per group) were treated with 25 ng multiwalled carbon nanotubes (NT) as an i.p. insult to induce fibrosis, together with chemical (β-aminoproprionitrile – BAPN) or miRNA LOX inhibitors, progesterone (Prog) or dexamethasone (Dex) for up to 7 days. Fibrotic lesion area and Picrosirius red staining of the diaphragm, and mRNA expression of fibrosis-related genes in abdominal wall peritoneal mesothelial cells (PMC) were measured. Effects of BAPN and DEX on collagen fibre alignment were observed by transmission electron microscopy (TEM). Isolated PMC were cultured with and without interleukin 1α (IL1α) and Prog to determine effects on lox mRNA in vitro. NT induced extensive fibrosis and collagen deposition on the diaphragm, that was significantly ameliorated by BAPN, LOX miRNA, Prog or Dex. BAPN and Dex disrupted ordered collagen fibre bundles induced by NT as observed by TEM. Expression of lox, col1a1, col3a1 and bmp1 mRNA in abdominal wall PMC were all significantly increased by NT, but this effect was inhibited by treatment for up to 7 days with Prog or Dex. Physiological levels of Prog significantly inhibited IL1α induced lox expression by PMC in vitro. Our results suggest targeting of LOX in the peritoneum may ameliorate fibrosis and the development of adhesions, and point to simple, naturally occurring or widely used steroids as potential agents to prevent adhesion formation following abdominal surgery.
- 23 February 2010
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1800 (6) , 611-618
Selenium supplementation attenuates procollagen-1 and interleukin-8 production in fat-loaded human C3A hepatoblastoma cells treated with TGFβ1
- 23 February 2010
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1800 (6) , 611-618
Selenium supplementation attenuates procollagen-1 and interleukin-8 production in fat-loaded human C3A hepatoblastoma cells treated with TGFβ1
- Open Access
- 4 May 2009
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 15 (6) , 379-392
Regulation of 3 -hydroxysteroid dehydrogenase type 1 and type 2 gene expression and function in the human ovarian surface epithelium by cytokines
The human ovarian surface epithelium (hOSE) is a squamous-to-cuboidal layer that surrounds the ovary. hOSE undergoes injury and repair cycles as a result of ovulation-induced inflammation, an event relevant to the development of epithelial ovarian cancer (EOC). Locally produced steroids mediate the response to inflammation. 3β-Hydroxysteroid dehydrogenase (3β-HSD) drives the intracrine generation of progestogens and androgens that potentially affect cell survival and proliferation. We therefore investigated the regulation of 3β-HSD along with downstream steroid signalling in hOSE. Double immunofluorescence of cultured primary hOSE cells confirmed the expression of 3β-HSD protein Interleukin (IL). IL-1α treatment of primary cells to mimic ovulation-associated inflammation suppressed 3β-HSD1 expression and stimulated 3β-HSD2 mRNA (P < 0.001), without affecting total 3β-HSD protein and activity or androgen or progesterone receptor (PR) mRNA levels. Conversely, IL-4 as a proxy for a post-ovulatory healing cytokine increased both 3β-HSD transcripts, total protein and activity (P < 0.01). IL-4 also suppressed androgen receptor expression (P < 0.01) without affecting that of the PR, thereby potentially sustaining both progesterone biosynthesis and its underlying signalling in the ovarian surface. 3β-HSD protein was immunodetectable in primary ascites of women who were diagnosed with EOC but both mRNA transcripts were diminished relative to normal cells (P < 0.05). Notably, this difference was countered by IL-4 treatment (P < 0.01). We conclude that stimulation by IL-4 could be physiologically relevant to post-ovulatory ovarian healing and suggest a novel therapeutic strategy for the activation of progesterone-associated apoptosis in ovarian cancer. Also, our results suggest an attenuation of 3β-HSD expression in EOC although further studies are required for confirmation.
- 4 May 2009
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 15 (6) , 379-392
Open AccessRegulation of 3 -hydroxysteroid dehydrogenase type 1 and type 2 gene expression and function in the human ovarian surface epithelium by cytokines
The human ovarian surface epithelium (hOSE) is a squamous-to-cuboidal layer that surrounds the ovary. hOSE undergoes injury and repair cycles as a result of ovulation-induced inflammation, an event relevant to the development of epithelial ovarian cancer (EOC). Locally produced steroids mediate the response to inflammation. 3β-Hydroxysteroid dehydrogenase (3β-HSD) drives the intracrine generation of progestogens and androgens that potentially affect cell survival and proliferation. We therefore investigated the regulation of 3β-HSD along with downstream steroid signalling in hOSE. Double immunofluorescence of cultured primary hOSE cells confirmed the expression of 3β-HSD protein Interleukin (IL). IL-1α treatment of primary cells to mimic ovulation-associated inflammation suppressed 3β-HSD1 expression and stimulated 3β-HSD2 mRNA (P < 0.001), without affecting total 3β-HSD protein and activity or androgen or progesterone receptor (PR) mRNA levels. Conversely, IL-4 as a proxy for a post-ovulatory healing cytokine increased both 3β-HSD transcripts, total protein and activity (P < 0.01). IL-4 also suppressed androgen receptor expression (P < 0.01) without affecting that of the PR, thereby potentially sustaining both progesterone biosynthesis and its underlying signalling in the ovarian surface. 3β-HSD protein was immunodetectable in primary ascites of women who were diagnosed with EOC but both mRNA transcripts were diminished relative to normal cells (P < 0.05). Notably, this difference was countered by IL-4 treatment (P < 0.01). We conclude that stimulation by IL-4 could be physiologically relevant to post-ovulatory ovarian healing and suggest a novel therapeutic strategy for the activation of progesterone-associated apoptosis in ovarian cancer. Also, our results suggest an attenuation of 3β-HSD expression in EOC although further studies are required for confirmation.
- 25 March 2009
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 301 (1-2) , 65-73
3β-Hydroxysteroid dehydrogenases and pre-receptor steroid metabolism in the human ovarian surface epithelium
- 25 March 2009
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 301 (1-2) , 65-73
3β-Hydroxysteroid dehydrogenases and pre-receptor steroid metabolism in the human ovarian surface epithelium
- 1 March 2009
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 300 (1-2) , 115-120
Estrogen biosynthesis in human H295 adrenocortical carcinoma cells
- 1 March 2009
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 300 (1-2) , 115-120
Estrogen biosynthesis in human H295 adrenocortical carcinoma cells